In situ and invasive squamous cell carcinoma of the vulva in Denmark 1978-2007-a nationwide population-based study

Gynecologic Oncology

Volumn 122, Issue 1, 2011, Pages 45-49

  Baandrup, L ^a   Varbo, A ^b   Munk, C ^a   Johansen, C ^a   Frisch, M ^c   Kjaer, S K ^a,b  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

Author keywords

Human papillomavirus; Incidence; Squamous cell carcinoma; Vulvar cancer

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER STAGING; CARCINOMA IN SITU; DENMARK; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VULVA CARCINOMA; VULVA SQUAMOUS CELL CARCINOMA; VULVAR CARCINOMA IN SITU;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; DENMARK; FEMALE; HUMANS; INCIDENCE; LINEAR MODELS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; VULVAR NEOPLASMS; YOUNG ADULT;

EID: 79957709092     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.03.016     Document Type: Article

References (26)

1. The National Board of Health. Cancer incidence in Denmark. web-Based Report http://www.sst.dk/publ/Publ2009/DOKU/Cancerreg/cancerregisteret-2008.pdf.
2. Bodelon C, Madeleine MM, Voigt LF, Weiss NS. Is the incidence of invasive vulvar cancer increasing in the United States? Cancer Causes Control 2009;20:1779-82.
3. Iversen T, Tretli S. Intraepithelial and invasive squamous cell neoplasia of the vulva: trends in incidence, recurrence, and survival rate in Norway. Obstet Gynecol 1998;91:969-72. (Pubitemid 28246933)
4. Joura EA, Losch A, Haider-Angeler MG, Breitenecker G, Leodolter S. Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med 2000;45:613-5. (Pubitemid 30661117)
5. Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol 2006;107:1018-22.
6. Sturgeon SR, Brinton LA, Devesa SS, Kurman RJ. In situ and invasive vulvar cancer incidence trends (1973 to 1987). Am J Obstet Gynecol 1992;166:1482-5.
7. Levi F, Randimbison L, La VC. Descriptive epidemiology of vulvar and vaginal cancers in Vaud, Switzerland, 1974-1994. Ann Oncol 1998;9:1229-32.
8. Hemminki K, Li X, Vaittinen P. Time trends in the incidence of cervical and other genital squamous cell carcinomas and adenocarcinomas in Sweden, 1958-1996. Eur J Obstet Gynecol Reprod Biol 2002;101:64-9.
9. Watson M, Saraiya M, Wu X. Update of HPV-associated female genital cancers in the United States, 1999-2004. J Womens Health 2009;18:1731-8.
10. Jones RW, Baranyai J, Stables S. Trends in squamous cell carcinoma of the vulva: the influence of vulvar intraepithelial neoplasia. Obstet Gynecol 1997;90:448-52. (Pubitemid 27357940)
11. Saraiya M, Watson M, Wu X, King JB, Chen VW, Smith JS, et al. Incidence of in situ and invasive vulvar cancer in the US, 1998-2003. Cancer 2008;113:2865-72.
12. Smith JS, Backes DM, Hoots BE, Kurman RJ, Pimenta JM. Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors. Obstet Gynecol 2009;113:917-24.
13. van dA I, Shirango H, Hoevenaars BM, Grefte JM, deHullu JA, deWilde PC, et al. Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways. Int J Gynecol Pathol 2006;25:22-9.
14. Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008;113:3036-46.
15. Hart WR. Vulvar intraepithelial neoplasia: historical aspects and current status. Int J Gynecol Pathol 2001;20:16-30. (Pubitemid 32041755)
16. Scurry J, Wilkinson EJ. Review of terminology of precursors of vulvar squamous cell carcinoma. J Low Genit Tract Dis 2006;10:161-9. (Pubitemid 44618506)
17. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry - history, content, quality and use. Dan Med Bull 1997;44:535-9.
18. Madsen BS, Jensen HL, van den Brule AJ, Wohlfahrt J, Frisch M. Risk factors for invasive squamous cell carcinoma of the vulva and vagina - population-based case-control study in Denmark. Int J Cancer 2008;122:2827-34. (Pubitemid 351631386)
19. Nielsen A, Kjaer SK, Munk C, Iftner T. Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12,000 younger and older Danish women. Sex Transm Dis 2008;35:276-82. (Pubitemid 351619532)
20. Kjaer SK, Chackerian B, van den Brule AJ, Svare EI, Paull G, Walbomers JM, et al. High-risk human papillomavirus is sexually transmitted: evidence from a followup study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomark Prev 2001;10:101-6. (Pubitemid 32172427)
21. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, De Sanjose S, Bruni L, et al. Epidemiology and natural history of human papillomavirus infections and typespecific implications in cervical neoplasia. Vaccine 2008;26S:K1-K16.
22. Kjaer SK, Breugelmans G, Munk C, Junge J, Watson M, Iftner T. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer 2008;123:1864-70.
23. Brinton LA, Nasca PC, Mallin K, Baptiste MS, Wilbanks GD, Richart RM. Casecontrol study of cancer of the vulva. Obstet Gynecol 1990;75:859-66.
24. Olesen TB, Jensen KE, Munk C, Tolstrup JS, Kjaer SK. "'Liva" - population survey of female sexual habits. Ugeskr Laeger 2010;172:3254-9.
25. Beller U, Quinn MA, Benedet JL, Creasman WT, Ngan HY, Maisonneuve P, et al. Carcinoma of the vulva. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006;95:S7-S27.
26. Munoz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, et al. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst 2010;102:325-39.